Let's collaborate and create quality liposome encapsulated drugs together. Contact Us!
SyVento BioTech is a biotechnology company offering comprehensive services in the development of lipid-based nanocarriers and LNP technology. We specialize in the development of lipid-based formulations for pharmaceutical products, including RNA-based drug products.
Genetic platform
SyVento BioTech’s R&D Team offers technical and scientific support throughout the entire process, including advice on troubleshooting and optimization of RNA synthesis conditions. Our RNA synthesis proficiency guarantees successful results in downstream applications.
By incorporating these important features, our genetic platform for RNA synthesis
provides:
Delivery platform
Our Team’s qualifications and experience provide a wealth of expertise in the development of lipid-based delivery systems.
SyVento BioTech’s LNP delivery systems:
Manufacturing platform
Our capabilities offer the possibility of scaling the production of formulations based on lipid nanocarriers by transferring solutions developed in the laboratory on a semi-technical and technical scale.
Thanks to the extensive equipment base, we are able to perform:
Drug development expertise
August 27, 2024
SyVentoBioTech presenting our Fill&Finish Expertise at CPHI Milan.SyVentoBioTech is excited to announce our participation at CPHI Milan, taking place in October 8-10 at Fiera Milano. CPHI Milan as a premier platform for the pharmaceutical industry, brings together a global network of experts and decision-makers from 166+ countries all over the globe and we are proud to join this vibrant community and contribute to the […]
August 19, 2024
SyVento BioTech to Participate in PHASE 2024 and Join Oxford-style DebateSyVento BioTech, as a leading CDMO specialized in lipid-based nanocarriers technology and production, together with aseptic clinical fill&finish, is excited to announce its participation in PHASE 2024, a premier event for the medical biotechnology industry. Taking place between 27th and 29th of August. PHASE 2024, as one of the most relevant forums of Polish medical […]
May 20, 2024
SyVento BioTech Fostering Connections at Pharma Partnering Summit!SyVento BioTech is excited to announce our participation in the prestigious Pharma Partnering Summit taking place in Basel, Switzerland, from May 22nd to 23rd, 2024, at the Mövenpick Hotel. Our esteemed representatives, Eliza Milewicz, Member of the Supervisory Board, and Tomasz Piec, Chairman of the Supervisory Board, will be actively engaged in this premier event. The […]
May 10, 2024
SyVento BioTech at the Forefront of Innovation: Attending TIDES USA 2024!SyVento BioTech is thrilled to announce our participation in the prestigious TIDES USA conference, taking place in Boston, MA, from May 14th to 17th, 2024, at the Hynes Convention Center. Our Chief Technology Officer, Dominik Lipka, will be actively engaged in this leading event, fostering connections and gathering knowledge at the forefront of oligonucleotide and peptide therapeutics. Why TIDES USA is […]
April 29, 2024
SyVento BioTech at the Forefront of LNP Innovation: Attending the 3rd Annual LNP Formulation & Process Development Summit!SyVento BioTech is excited to announce our participation in the highly anticipated 3rd Annual LNP Formulation & Process Development Summit taking place in Boston, MA, from April 29th to May 2nd, 2024. Our esteemed delegates, Dominik Lipka and Olga Długosz Grochowska, will be actively engaged in the summit, attending not only the core conference sessions but also delving deeper with […]
April 17, 2024
Meet our Team on LSX World Conference 2024: Bridging Innovations in Life SciencesLondon, April 29-30, 2024 The LSX World Conference, a premier event in the life sciences industry, convened today in London, bringing together global leaders, innovators, and investors to explore the latest trends and advancements in healthcare, biotechnology, and pharmaceuticals. Hosted by Informa Connect, the conference promises to be a dynamic platform for networking, knowledge exchange, […]
April 17, 2024
SyVento BioTech Showcases Innovation and Collaboration on Swiss BioTech Day 2024 in BaselSwitzerland, renowned for its cutting-edge advancements in the field of biotechnology, once again played host to the prestigious Swiss BioTech Day in Basel. The event, held annually, serves as a pivotal platform for industry leaders, researchers, investors, and enthusiasts to converge, exchange ideas, and foster collaborations aimed at driving the future of biotech innovation. This […]
March 13, 2024
SyVento BioTech at RNA Leaders ConferenceSyvento, a leading biotechnology company in RNA therapeutics, emerged at the recent RNA Leaders conference between March 13-14, 2024 in Basel, Switzerland. Throughout the event, Syvento showcased its innovative contributions to the field by exhibiting at booth no. 21. Visitors to the booth had the opportunity to engage with Syvento’s representatives, learn about the company’s […]
January 30, 2024
Leveraging Insights from the 3rd mRNA Analytical Development Summit for Enhanced mRNA TherapeuticsSyVento BioTech is committed to staying at the forefront of mRNA therapeutics development. Our participation in the upcoming 3rd mRNA Analytical Development Summit is a testament to this commitment. Representing us at this pivotal event are our CTO, Dominik Lipka PhD Eng., and Marcelina Radko-Zwierzyńska, Manager of Research and Quality Control Laboratory. The summit promises […]
Let's collaborate and create quality liposome encapsulated drugs together.